Search Orphan Drug Designations and Approvals
-
| Generic Name: | allogeniec Human Pancreatic Islets of Langerhans |
|---|---|
| Date Designated: | 05/01/2019 |
| Orphan Designation: | Treatment of brittle type 1 diabetes |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Diabetes Research Institute & Cell Transplant Center, Univ of Miami 1450 NW 10th Avenue Miami, Florida 33136 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







